{"title":"Risk factors on length of stay among pulmonary tuberculosis patients: A systematic review and meta-analysis","authors":"Dao Weiangkham , Adinat Umnuaypornlert , Surasak Saokaew , Neeranuch Wongcharoen , Samrerng Prommongkol , Jutamas Ponmark","doi":"10.1016/j.ijnsa.2025.100316","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Pulmonary Tuberculosis (PTB) remains a pressing public health concern. Long hospital stays for PTB patients can overburden both patients and healthcare systems.</div></div><div><h3>Objective</h3><div>To identify the key factors contributing to extended length of stay in PTB patients.</div></div><div><h3>Information sources</h3><div>Four electronic databases (PubMed, Scopus, Embase, and CINAHL) were systematically searched from inception to January 1, 2023.</div></div><div><h3>Methods</h3><div>The articles were screened and performed according to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). Inclusion criteria were PTB patients diagnosed by doctors and studies reporting factors affecting length of stay. Exclusion criteria were review articles, case study, conferences abstract, and proceedings. Study quality was assessed using the Newcastle-Ottawa Scale (NOS). A random-effects model was used to analyzed risk factors for length of stay. Heterogeneity was employed using I<sup>2</sup> and Q statistics. Forest plots displayed effect sizes (ES) and 95 % confidence intervals. STATA 14.2 was used for meta-analysis.</div></div><div><h3>Results</h3><div>A total of 1,190 studies were screened from reputable electronic databases, six studies comprised of 9,231 participants were included. Meta-analysis revealed that they are six risk factors associated with longer length of stay including; older age (OR 1.50, 95 % CI 1.07–2.09, <em>p</em> = 0.019), comorbidity (OR 1.44, 95 % CI 1.17–1.78, <em>p</em> = 0.001), HIV patient (OR 1.40, 95 % CI 1.16–1.69, <em>p</em> = 0.001), patients with ADR (OR 2.19, 95 % CI 1.47–3.26, <em>p</em> < 0.001), MDR TB (OR 3.16, 95 % CI 2.31–4.32, <em>p</em> < 0.001), and miliary TB (OR 1.37, 95 % CI 1.10–1.70, <em>p</em> = 0.004) with minimal heterogeneity [(I<sup>2</sup> = 34.2 %, <em>p</em> = 0.207), (I<sup>2</sup> = 43.1 %, <em>p</em> = 0.118), (I<sup>2</sup> = 0.0 %, <em>p</em> = 0.573), (I<sup>2</sup> = 0.0 %, <em>p</em> = 0.723), (I<sup>2</sup> = 0.0 %, <em>p</em> = 0.366), and (I<sup>2</sup> = 0.0 %, <em>p</em> = 0.753), respectively]. There was no evidence of publication bias according to Begg's and Egger's test.</div></div><div><h3>Conclusions</h3><div>In conclusion, six risk factors were identified as significantly associated with longer hospital stays in PTB patients: older age, comorbidities, HIV infection, ADR, MDR-TB, and miliary TB. These findings highlight the importance of targeted interventions for these high-risk groups to reduce length of stay and alleviate the burden on healthcare systems. The results are based on a meta-analysis of six studies with minimal heterogeneity, and no evidence of publication bias was found. Future research should focus on exploring additional factors influencing length of stay, particularly in diverse populations, and evaluating the effectiveness of interventions to shorten hospital stays. Additionally, studies examining the impact of healthcare infrastructure and resource allocation on length of stay could provide valuable insights for improving patient outcomes.</div></div><div><h3>Registration</h3><div>This study was registered with PROSPERO, CRD4203390615</div></div>","PeriodicalId":34476,"journal":{"name":"International Journal of Nursing Studies Advances","volume":"8 ","pages":"Article 100316"},"PeriodicalIF":3.1000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nursing Studies Advances","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666142X25000268","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Pulmonary Tuberculosis (PTB) remains a pressing public health concern. Long hospital stays for PTB patients can overburden both patients and healthcare systems.
Objective
To identify the key factors contributing to extended length of stay in PTB patients.
Information sources
Four electronic databases (PubMed, Scopus, Embase, and CINAHL) were systematically searched from inception to January 1, 2023.
Methods
The articles were screened and performed according to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). Inclusion criteria were PTB patients diagnosed by doctors and studies reporting factors affecting length of stay. Exclusion criteria were review articles, case study, conferences abstract, and proceedings. Study quality was assessed using the Newcastle-Ottawa Scale (NOS). A random-effects model was used to analyzed risk factors for length of stay. Heterogeneity was employed using I2 and Q statistics. Forest plots displayed effect sizes (ES) and 95 % confidence intervals. STATA 14.2 was used for meta-analysis.
Results
A total of 1,190 studies were screened from reputable electronic databases, six studies comprised of 9,231 participants were included. Meta-analysis revealed that they are six risk factors associated with longer length of stay including; older age (OR 1.50, 95 % CI 1.07–2.09, p = 0.019), comorbidity (OR 1.44, 95 % CI 1.17–1.78, p = 0.001), HIV patient (OR 1.40, 95 % CI 1.16–1.69, p = 0.001), patients with ADR (OR 2.19, 95 % CI 1.47–3.26, p < 0.001), MDR TB (OR 3.16, 95 % CI 2.31–4.32, p < 0.001), and miliary TB (OR 1.37, 95 % CI 1.10–1.70, p = 0.004) with minimal heterogeneity [(I2 = 34.2 %, p = 0.207), (I2 = 43.1 %, p = 0.118), (I2 = 0.0 %, p = 0.573), (I2 = 0.0 %, p = 0.723), (I2 = 0.0 %, p = 0.366), and (I2 = 0.0 %, p = 0.753), respectively]. There was no evidence of publication bias according to Begg's and Egger's test.
Conclusions
In conclusion, six risk factors were identified as significantly associated with longer hospital stays in PTB patients: older age, comorbidities, HIV infection, ADR, MDR-TB, and miliary TB. These findings highlight the importance of targeted interventions for these high-risk groups to reduce length of stay and alleviate the burden on healthcare systems. The results are based on a meta-analysis of six studies with minimal heterogeneity, and no evidence of publication bias was found. Future research should focus on exploring additional factors influencing length of stay, particularly in diverse populations, and evaluating the effectiveness of interventions to shorten hospital stays. Additionally, studies examining the impact of healthcare infrastructure and resource allocation on length of stay could provide valuable insights for improving patient outcomes.
Registration
This study was registered with PROSPERO, CRD4203390615
背景肺结核(PTB)仍然是一个紧迫的公共卫生问题。肺结核患者长期住院可能使患者和医疗保健系统负担过重。目的探讨影响肺结核患者住院时间延长的关键因素。信息来源系统检索了四个电子数据库(PubMed, Scopus, Embase和CINAHL),从成立到2023年1月1日。方法根据首选报告项目进行系统评价和meta分析(PRISMA)。纳入标准是由医生诊断的肺结核患者和研究报告影响住院时间的因素。排除标准为综述文章、案例研究、会议摘要和会议记录。采用纽卡斯尔-渥太华量表(NOS)评估研究质量。采用随机效应模型分析住院时间的危险因素。异质性采用I2和Q统计。森林图显示了效应量(ES)和95%置信区间。采用STATA 14.2进行meta分析。结果共从知名电子数据库中筛选出1190项研究,纳入6项研究,9231名受试者。荟萃分析显示,与住院时间延长相关的六个风险因素包括;年龄较大(OR 1.50, 95% CI 1.07-2.09, p = 0.019),合并症(OR 1.44, 95% CI 1.17-1.78, p = 0.001), HIV患者(OR 1.40, 95% CI 1.16-1.69, p = 0.001),不良反应患者(OR 2.19, 95% CI 1.47-3.26, p <;0.001),耐多药结核病(OR 3.16, 95% CI 2.31-4.32, p <;(OR 1.37, 95% CI 1.10-1.70, p = 0.004),异质性最小[I2 = 34.2%, p = 0.207], (I2 = 43.1%, p = 0.118), (I2 = 0.0%, p = 0.573), (I2 = 0.0%, p = 0.723), (I2 = 0.0%, p = 0.366), (I2 = 0.0%, p = 0.753]。根据贝格和埃格的检验,没有证据表明发表偏倚。结论结论:年龄、合并症、HIV感染、ADR、MDR-TB和军人结核等6个危险因素与PTB患者住院时间延长显著相关。这些发现强调了对这些高危人群进行有针对性的干预以减少住院时间和减轻医疗保健系统负担的重要性。该结果基于对六项研究的荟萃分析,具有最小的异质性,没有发现发表偏倚的证据。未来的研究应侧重于探索影响住院时间长短的其他因素,特别是在不同的人群中,并评估缩短住院时间的干预措施的有效性。此外,检查医疗基础设施和资源分配对住院时间影响的研究可以为改善患者结果提供有价值的见解。本研究已在普洛斯彼罗注册,编号为CRD4203390615